Authors
Surya Kiran Sharma
Abstract
In the world, Epilepsy is known as the communal severe disorder related with neurological factors. Women with epilepsy i.e. WWE understanding numerous physical and social problem related with gender. At the time of pregnancy, the chief concerns linked with epilepsy that contains fetal and maternal threat from abandoned attacks, and damaging effects of handling on the growth of young ones. In pregnant women, increasing the risk of safety whenever an antiepileptic drug is taken by patients but this drug is not totally safe to use in pregnancy as the danger of fetal aberration is improved. Before conception, planning must be done for managing the women’s epilepsy during pregnancy. Without medical advice, the existence of an unexpected pregnancy must not be treated with quick alteration or cessation of an antiepileptic drug. In this case, should be used the minimum effective amount of a drug with a small threat of teratogenicity. During pregnancy, doses or amount may require modification as the pharmacokinetics of particular drugs. In this paper, discussed about the using the antiepileptic drug at the time of pregnancy and security of antiepileptic drug use at the time of pregnancy. Keyword: Antiepileptic drug, Teratogenicity, Epilepsy, Pregnant women
Introduction
Epilepsy is considered as communal chronic neurological problem in which, pregnant female have a severe and possibly dangerous condition for both infant as well as mother and essentially used the constant pharmacological medication all over pregnancy. With epilepsy, most pregnant women need to take at least one antiepileptic drug (AED) and this drug is recommended to decrease the seriousness of epilepsy or support to achieve the situations like pain, psychiatric disorders, and migraine. Female compelling AED have a danger of teratogenicity and miscarriage, consisting a 4-8% probability of giving natal to a child having maximum congenital malformation (CM) for the reason that these agents can be removed from placenta to fetus. Teratogenicity of AED was first documentation in the 1960s, in pregnant women with epilepsy, the practice of numerous first-generation AEDs (Valporate) has been studied extensively.
In pregnancy, use of the antiepileptic drug for safety purpose contains the pregnant women in itself condition; the fetus though in her womb, and through its following extra-uterine presence as a newborn. The safety of antiepileptic drugs during pregnancy is not meaningfully diverse from the care of these drug in normal women, except in case of normal women, these drugs are affecting on the pregnant lady and drugs effect on the foetus in utero and afterward. But in current years, antiepileptic drugs have been utilizes in increasingly to treat the illnesses besides epilepsy.
In the United States, around 1.3 million female suffering with epilepsy are in their lively reproductive years and give birth to 25,000 newborns every year. With the favorable outcome, most female having epilepsy will consist an ordinary pregnancy but there are more fetal and maternal danger likened to the overall population. On developing offspring, fall the effects of ADE include both anatomic teratogenic and neurodevelopment significances. Female suffering with epilepsy have offspring on AEDs that are at an major risk for intrauterine growth hindrance, cognitive dysfunction, minor anomalies, major congenital malformations, microcephaly, and infant mortality. “Fetal anticonvulsant syndrome” is consider as something which is utilize to contain various combination of these outcomes.
References
Bech, B.h., et al. “Use of Antiepileptic Drugs During Pregnancy and Risk of Spontaneous Abortion and Stillbirth.” Obstetric Anesthesia Digest, vol. 35, no. 3, 2015, p. 139., doi:10.1097/01.aoa.0000469474.65223.81.
Brodtkorb, Eylert, and Arne Reimers. “Seizure Control and Pharmacokinetics of Antiepileptic Drugs in Pregnant Women with Epilepsy.” Seizure, vol. 17, no. 2, 2008, pp. 160–165., doi:10.1016/j.seizure.2007.11.015.
Clemow, David B., et al. “Clinical Data for Informed Medication Use in Pregnancy.” Therapeutic Innovation & Regulatory Science, vol. 48, no. 2, 2014, pp. 134–144., doi:10.1177/2168479014523006.
Davanzo,, Riccardo, et al. “Antiepileptic Drugs and Breastfeeding.” Italian Journal of Pediatrics, vol. 39, Aug. 2013, pp. 1–11.
Eadie, Mervyn J. “Antiepileptic Drug Safety in Pregnancy: Possible Dangers for the Pregnant Woman and Her Foetus.” The Pharmaceutical Journal: A Royal Pharmaceutical Society Publication, 15 Jan. 2016.
Ferri, M. Martinez, et al. “Comparative Study of Antiepileptic Drug Use during Pregnancy over a Period of 12 Years in Spain. Efficacy of the Newer Antiepileptic Drugs Lamotrigine, Levetiracetam, and Oxcarbazepine.” Neurología (English Edition), vol. 33, no. 2, 2018, pp. 78–84., doi:10.1016/j.nrleng.2016.05.008.
Hernandez-Diaz, S., et al. “Comparative Safety of Antiepileptic Drugs during Pregnancy.” Neurology, vol. 78, no. 21, Feb. 2012, pp. 1692–1699., doi:10.1212/wnl.0b013e3182574f39.
Kulaga, Sophie, et al. “Antiepileptic Drug Use during Pregnancy: Perinatal Outcomes.” Seizure, vol. 20, no. 9, 2011, pp. 667–672., doi:10.1016/j.seizure.2011.06.012.
Lander, Cecilie M. “Antiepileptic Drugs in Pregnancy and Lactation.” Australian Prescriber , vol. 31, no. 3, June 2008, pp. 70–72.
Pem, Tshering, et al. “Safe and Unsafe Drugs during Pregnancy.” Journal of Chemical and Pharmaceutical Research, vol. 8, no. 3, 2016, pp. 652–663.
Pennell, Page B. “Antiepileptic Drugs during Pregnancy: What Is Known and Which AEDs Seem to Be Safest?” Epilepsia, vol. 49, 2008, pp. 43–55., doi:10.1111/j.1528-1167.2008.01926.x.
Pennell, Page B. “Using Current Evidence in Selecting Antiepileptic Drugs for Use during Pregnancy.” Epilepsy Currents, vol. 5, no. 2, 2005, pp. 45–51., doi:10.1111/j.1535-7597.2005.05201.x.
Thomas SV. “Management of Epilepsy and Pregnancy.” J Postgrad Med, vol. 52, no. 1, Mar. 2006, pp. 58–64.
Veroniki, Areti Angeliki, et al. “Comparative Safety of Anti-Epileptic Drugs during Pregnancy: a Systematic Review and Network Meta-Analysis of Congenital Malformations and Prenatal Outcomes.” BMC Medicine, vol. 15, no. 1, May 2017, doi:10.1186/s12916-017-0845-1.
Widnes, Sofia Frost, et al. “Risk Perception and Medicines Information Needs in Pregnant Women with Epilepsy – A Qualitative Study.” Seizure, vol. 21, no. 8, 2012, pp. 597–602., doi:10.1016/j.seizure.2012.06.007.
How to cite this article?
| APA Style | Sharma, S. K. (2019). The Use Antiepileptic Drug (AED) during Pregnancy. Academic Journal of Modern Applied Sciences, 1(1), 12-18 |
| Chicago Style | |
| MLA Style | |
| DOI | |
| URL |